Skip to content

Clinical study on evaluating the efficacy of traditional Chinese medicine acupuncture in patients with acute gastrointestinal injury based on ultrasound monitoring

Clinical study on evaluating the efficacy of traditional Chinese medicine acupuncture in patients with acute gastrointestinal injury based on ultrasound monitoring

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200058267
Enrollment
Unknown
Registered
2022-04-04
Start date
2022-04-01
Completion date
Unknown
Last updated
2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute gastrointestinal injury (AGI)

Interventions

Experimental group:Acupuncture + conventional western medicine treatment
Control group:Conventional western medicine treatment

Sponsors

Hospital of Chengdu University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-80 years; 2. Meet the diagnostic criteria of Grade I-III in acute gastrointestinal injury; 3. Informed consent to the treatment protocol in this study.

Exclusion criteria

Exclusion criteria: 1. ICU stay less than 3 days; 2. Pregnant and lactating women who have fertility requirements in the past six months; 3. Patients with advanced malignant tumor and significantly shortened life expectancy; 4. Patients with severe digestive diseases (such as acute gastrointestinal massive bleeding, mechanical ileus, major abdominal surgery, and celiac compartment syndrome) who cannot be given standard therapeutic drugs through the intestine; 5. Patients with hemodynamic instability that cannot guarantee delivery of standard therapeutic drugs through the intestine; 6. During the intervention of this study, the patient's family members voluntarily requested to give up the treatment, which resulted in the death of the patient; 7. Patients with skin damage at the acupuncture site, which is not suitable for acupuncture; 8. Participating in other clinical trials.

Design outcomes

Primary

MeasureTime frame
Gastric antrum diameter;Gastric residual volume;Intestinal diameter;Intestinal wall thickness;Gastrointestinal motility;Tissue perfusion;Sequential Organ Failure Score (SOFA);Acute Physiology and Chronic Health Evaluation II Score;28-day and 90-day mortality rate;

Secondary

MeasureTime frame
ICU stay time;

Countries

China

Contacts

Public ContactDing Peng

Hospital of Chengdu University of Traditional Chinese Medicine

dinglq1021@163.com+86 18380456616

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026